AzTrials
AzTrials

Caries ExperienceNCT06932939

Comparison of CAMBRA123 and AAPD (CAT) for Caries Risk in Egyptian Children

An observational study of Caries Experience, run by Cairo University at 1 site in Egypt.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This study goal is to compare two indices in Egyptian children aged 3-6 years in caries detection and time needed for assessment which will contribute to variable data for pediatric oral health assessment locally and globally. Read more about this study

Who is it for?
Ages 3 to 6 yearsHealthy volunteers can take part
Conditions the study is for
Caries Experience
How many people
376 participants
Where
1 siteEgypt
Study dates
1 Jun 2025to 1 Jul 2025
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 6 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Study population: This study will be conducted at the outpatient clinics of the Pediatric and Dental Public Health Department among group of (3-6) years old- Faculty of Dentistry, Cairo University - Egypt.

Who may be able to join

  • Children aged 3 to 6 years.
  • Both genders.
  • No underlying medical conditions affecting oral health.

Who cannot join

  • Uncooperative patient.
  • Children with cognitive impairments that prevent understanding the study procedures.
  • Parents refused.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Hanaa Mohamed AlKarib, master degree contact

+201096790172 ext. +201055151391

hanaa.elkarib@gmail.com

Egypt1 site
  • Faculty of Dentistry Cairo University

    Cairo, Giza Governorate, 12613

    Hanaa Mohamed Alkarib, master degree, +201096790172 ext. +201055151391, hanaa.elkarib@gmail.com

    Sherine Ezz El-Din, PHD, +201096790172 ext. +201055151391, sherine.taha@dentistry.cu.edu.eg

Other trials in Egypt

About this study

Official title: Comparison of Two Caries Risk Assessment Tools CAMBRA123 Versus (CAT) AAPD Among a Group of Egyptian Children: A Cross- Sectional Study

This study goal is to compare two indices in Egyptian children aged 3-6 years in caries detection and time needed for assessment which will contribute to variable data for pediatric oral health assessment locally and globally.

Read the detailed description

This study will ensure that patients receive precise evaluations and guide early, appropriate preventive measures or treatments. Over time, this will contribute to reducing caries progression and related complications. Also, Parents become more aware of their children's dental health status, emphasizing the importance of early detection and intervention. Furthermore, Comparing the indices will provide insights into which tool is most efficient and reliable for detecting caries in children 3-6 years old.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Caries risk assessment using AAPD

    Caries risk will be categorized as Low, Moderate, or High based on the American Academy of Pediatric Dentistry (AAPD) criteria.

    • Unit of Measure: Category (Low / Moderate / High)

    Measured: baseline (single visit)

  2. Caries risk assessment using CAMBRA123

    Caries risk will be evaluated using the CAMBRA 123 scoring system, which assigns scores from -4 to +18, categorized as:

    • Low: -4 to -1
    • Moderate: 0 to +3
    • High: +4 to +13
    • Very High: +14 to +18

    Measured: baseline (single visit)

Secondary outcomes (1)
  1. Time For index Application

    The time required to apply each caries assessment index (CAMBRA123 and AAPD) will be measured in seconds for each child during the clinical examination

    Measured: baseline (single visit)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Apr 2025
  2. Study start1 Jun 2025 (estimated)
  3. Primary completion1 Jul 2025 (estimated)
  4. Study completion1 Jul 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
376 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06932939
Sponsor's protocol ID
CTCRATCVA-AAGOEC-2025
Status last verified
Apr 2025
First submitted
10 Apr 2025
Last updated
20 Apr 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Featherstone JDB, Crystal YO, Alston P, Chaffee BW, Domejean S, Rechmann P, Zhan L, Ramos-Gomez F. A Comparison of Four Caries Risk Assessment Methods. Front Oral Health. 2021 Apr 28;2:656558. doi: 10.3389/froh.2021.656558. eCollection 2021.

    PubMed 35048004
  • Devraj IM, Shankaraguru GM, Jairam LS, Dhull KS, Bhojraj N. Comparison of two different caries risk assessment tools for infants and toddlers - A cross-sectional study. J Indian Soc Pedod Prev Dent. 2024 Jan 1;42(1):9-14. doi: 10.4103/jisppd.jisppd_546_23. Epub 2024 Apr 15.

    PubMed 38616421

Questions about this trial

What is this clinical trial studying?

An observational study of Caries Experience, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 20 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Hanaa Mohamed AlKarib, master degree (+201096790172 ext. +201055151391, hanaa.elkarib@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Caries risk assessment using AAPD (time frame: baseline (single visit)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06932939, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Apr 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in